Abstract
Phyllodes tumours of the breast are rare tumours, accounting for 0.3–0.9% of breast tumours, and 2–3% of fibroepithelial tumours of the breast [3]. Phyllodes tumours have been described since 1982. The World Health Organization (WHO) proposed a classification with three distinct types: benign, borderline and malignant phyllodes tumours [11]. The pathological features classically used to distinguish these three categories are stromal cellularity, cell pleiomorphism, number of mitoses, margins, stromal pattern, and stromal differentiation. It is interesting to notice that malignant tumours have sarcomatous features with a metastatic potential, and although controversial, their prognosis is probably similar to that of non-phyllodes sarcomas of the breast [12]. The management of phyllodes tumours is mainly surgical, but controversies still remain concerning the type of surgery — conservative or not — especially for borderline and malignant forms, and about the role of adjuvant treatments (such as radiation therapy and chemotherapy). We propose to discuss these different points.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barth RJ Jr (1999) Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Breast Cancer Res Treat 57(3): 291–5
Belkacémi Y, Bousquet G, Marsiglia H et al. (2008) Phyllodes tumor of the breast. Int J Radiat Oncol Biol Phys 70(2): 492–500
Geisler DP, Boyle MJ, Malnar KF et al. (2000) Phyllodes tumors of the breast: a review of 32 cases. Am Surg 66(4): 360–6
Grabowski J, Salzstein SL, Sadler GR, Blair SL (2007) Malignant phyllodes tumors: a review of 752 cases. Am Surg 73(10): 967–9
Kapiris I, Nasiri N, A’Hern R et al. (2001) Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumours of the breast. Eur J Surg Oncol 27: 723–30
Le Cesne A, Van Glabbeke M, Woll PJ et al. (2008) The end of adjuvant chemotherapy (adCT) era with doxorubicin-based regimen in resected high-grade soft tissue sarcoma (STS): Pooled analysis of the two STBSG-EORTC phase III clinical trials. J Clin Oncol 26(suppl): abstr 10525
Macdonald OK, Lee CM, Tward JD et al. (2006) Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program. Cancer 107(9): 2127–33
Pezner RD, Schultheiss TE, Paz IB (2008) Malignant phyllodes tumor of the breast: local control rates with surgery alone. Int J Radiat Oncol Biol Phys 71(3): 710–3
Singh G, Sharma RK (2008) Immediate breast reconstruction for phyllodes tumors. Breast 17(3): 296–301
Tse GM, Lui PC, Lee CS et al. (2004) Stromal expression of vascular endothelial growth factor correlates with tumor grade and microvessel density in mammary phyllodes tumors: a multicenter study of 185 cases. Hum Pathol 35(9): 1053–7
The world Health Organization Histological Typing of Breast Tumors — Second Edition. The World Organization. Am J Clin Pathol 1982 Dec;78(6): 806–16
Zelek L, Llombart-Cussac A, Terrier P et al. (2003) Prognostic factors in primary breast sarcomas: a series of patients with long-term follow-up. J Clin Oncol 21(13): 2583–8
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag France, Paris
About this chapter
Cite this chapter
Bousquet, G., Bonneterre, J., Belkacémi, Y. (2009). Phyllodes tumours of the breast. In: Belkacémi, Y., Mirimanoff, RO., Ozsahin, M. (eds) Management of Rare Adult Tumours. Springer, Paris. https://doi.org/10.1007/978-2-287-92246-6_41
Download citation
DOI: https://doi.org/10.1007/978-2-287-92246-6_41
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-92245-9
Online ISBN: 978-2-287-92246-6
eBook Packages: MedicineMedicine (R0)